Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovering and developing engineered antibody therapeutics to treat patients with cancer and110.49M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States110.49M100.00%